Active	Status	Sponsor type	Region	Phase	Filter
3 Active 9 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Miller, Scott
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Recruiting	3	10000	Europe, Canada, US, RoW	Retatrutide, LY3437943, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)	02/29	02/29
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy	Recruiting	1/2	192	Canada, US	Peanut SLIT-tablet, Placebo	ALK-Abelló A/S, Parexel	Peanut Allergy	01/26	02/26
BA3011-001, NCT03425279: CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients with Sarcoma	Active, not recruiting	1/2	300	US, RoW	CAB-AXL-ADC, PD-1 inhibitor	BioAtla, Inc.	Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma	01/25	01/25
Dobson, Sean
No trials found